Donia M. Moujalled

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

András Kotschy, Zoltán Szlávik, James B. Murray et al. · Nature · 2016 · 1K citations

Mcl1 Inhibitor S63845, Systems Biology, Oncology +11

AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies

Sean Caenepeel, Sean P. Brown, Brian Belmontes et al. · Cancer Discovery · 2018 · 408 citations · Full text

Mitochondrial apoptosis is dispensable for <scp>NLRP</scp> 3 inflammasome activation but non‐apoptotic caspase‐8 is required for inflammasome priming

Ramanjaneyulu Allam, Kate E. Lawlor, Eric Yu et al. · EMBO Reports · 2014 · 240 citations · Full text

Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia

Donia M. Moujalled, Giovanna Pomilio, Corina Ghiurau et al. · Leukemia · 2018 · 168 citations · Full text

Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1

T.-C. Teh, N-Y Nguyen, Donia M. Moujalled et al. · Leukemia · 2017 · 149 citations

Hematological Malignancy, Tumor Biology, Mixed-phenotype Acute Leukemia +10